Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Assmann

Showing results (331-340 of 495) with videos related to

Pageof 50
Sort By:
The Journal of Biological Chemistry|March 10, 1984
Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 typeH J Menzel, G Assmann, S C Rall, et al.
Rheumatology (Oxford, England)|August 12, 2004
Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune responseH Schotte, M Gaubitz, P Willeke, et al.
European Journal of Clinical Nutrition|January 18, 2007
Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanolsM Kratz, F Kannenberg, E Gramenz, et al.
Metabolism: Clinical and Experimental|March 21, 1998
Basal growth hormone levels in women are positively correlated with high-density lipoprotein cholesterol and apolipoprotein A-I independently of insulin-like growth factor 1 or insulinD Bänsch, C Chen-Haudenschild, A Dirkes-Kersting, et al.
Diabetes|July 25, 2000
Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levelsD Q Shih, H M Dansky, M Fleisher, et al.
The Journal of Clinical Investigation|January 1, 1991
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacitiesH Funke, A von Eckardstein, P H Pritchard, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
EPO treatment after myocardial infarction in mice improves cardiac function by enhanced homing of bone marrow-derived cellsS Brunner, J Winogradow, B Huber, et al.
Atherosclerosis|January 3, 1997
The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilanoE Bruckert, A von Eckardstein, H Funke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 1998
HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphateJ R Nofer, M Walter, B Kehrel, et al.
International Journal of Clinical Practice|February 1, 2007
Erectile dysfunction as a risk factor for coronary heart disease: implications for preventionM J Tikkanen, G Jackson, T Tammela, et al.
Pageof 50

Showing results (331-340 of 495) with videos related to

Sort By:
Pageof 50
The Journal of Biological Chemistry|March 10, 1984
Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 typeH J Menzel, G Assmann, S C Rall, et al.
Rheumatology (Oxford, England)|August 12, 2004
Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune responseH Schotte, M Gaubitz, P Willeke, et al.
European Journal of Clinical Nutrition|January 18, 2007
Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanolsM Kratz, F Kannenberg, E Gramenz, et al.
Metabolism: Clinical and Experimental|March 21, 1998
Basal growth hormone levels in women are positively correlated with high-density lipoprotein cholesterol and apolipoprotein A-I independently of insulin-like growth factor 1 or insulinD Bänsch, C Chen-Haudenschild, A Dirkes-Kersting, et al.
Diabetes|July 25, 2000
Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levelsD Q Shih, H M Dansky, M Fleisher, et al.
The Journal of Clinical Investigation|January 1, 1991
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacitiesH Funke, A von Eckardstein, P H Pritchard, et al.
Journal of Stem Cells & Regenerative Medicine|April 3, 2014
EPO treatment after myocardial infarction in mice improves cardiac function by enhanced homing of bone marrow-derived cellsS Brunner, J Winogradow, B Huber, et al.
Atherosclerosis|January 3, 1997
The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilanoE Bruckert, A von Eckardstein, H Funke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 1998
HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphateJ R Nofer, M Walter, B Kehrel, et al.
International Journal of Clinical Practice|February 1, 2007
Erectile dysfunction as a risk factor for coronary heart disease: implications for preventionM J Tikkanen, G Jackson, T Tammela, et al.
Pageof 50